Catalytic asymmetric reductive hydroalkylation of enamides and enecarbamates to chiral aliphatic amines
Jia-Wang Wang,Yan Li,Wan Nie,Zhe Chang,Zi-An Yu,Yi-Fan Zhao,Xi Lu,Yao Fu
DOI: https://doi.org/10.1038/s41467-021-21600-x
IF: 16.6
2021-02-26
Nature Communications
Abstract:Abstract To increase the reliability and success rate of drug discovery, efforts have been made to increase the C( sp 3 ) fraction and avoid flat molecules. sp 3 -Rich enantiopure amines are most frequently encountered as chiral auxiliaries, synthetic intermediates for pharmaceutical agents and bioactive natural products. Streamlined construction of chiral aliphatic amines has long been regarded as a paramount challenge. Mainstream approaches, including hydrogenation of enamines and imines, C–H amination, and alkylation of imines, were applied for the synthesis of chiral amines with circumscribed skeleton structures; typically, the chiral carbon centre was adjacent to an auxiliary aryl or ester group. Herein, we report a mild and general nickel-catalysed asymmetric reductive hydroalkylation to effectively convert enamides and enecarbamates into drug-like α-branched chiral amines and derivatives. This reaction involves the regio- and stereoselective hydrometallation of an enamide or enecarbamate to generate a catalytic amount of enantioenriched alkylnickel intermediate, followed by C–C bond formation via alkyl electrophiles.
multidisciplinary sciences